Breast implant litigation
Claims allege that certain textured breast implants are linked to BIA‑ALCL, a lymphoma of the immune system that develops in the capsule around the implant.
Free case review
What the claims allege
In 2019, Allergan recalled its BIOCELL textured implants worldwide after regulators connected the texturing to BIA-ALCL. The litigation alleges manufacturers knew texturing increased lymphoma risk years before the recall, and continues on behalf of women diagnosed after explant.
Injuries named in the litigation
- BIA-ALCL (anaplastic large cell lymphoma)
- Late seroma and capsule swelling
- Implant removal and capsulectomy
Who may qualify
If you received textured breast implants and were diagnosed with BIA-ALCL or a persistent late seroma, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.